Orphan Drugs: Understanding the Rare Disease Ma, Hernberg-Stahl, Reljanovic,#
Orphan DrugsUnderstanding the Rare Disease Market and its Dynamics\nAuthor(s): Elizabeth Hernberg-Stahl, Miroslav Reljanovi?\nFormat: Hardback\nPublisher: Elsevier Science & Technology, United Kingdom\nImprint: Woodhead Publishing Ltd\nISBN-13: 9781907568091, 978-1907568091\nSynopsis\nThis authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient [url] journey from application of an orphan drug designation to a reimbursed market.
Compare prices (3 shops)
| shop | Price | Action |
|---|---|---|
|
128,19 GBP | Go to shop |
|
|
138,60 GBP | Go to shop |
|
|
138,76 GBP | Go to shop |
Similar products
-
-
-
-
Mathematical Tools for Understanding Infectious Disease Dynamics
From 103,15 EUR -
-
